Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
Samsung Biologics achieved an annual revenue of 4.5 trillion won in 2025. It has been evaluated that the company has...
Search results for "CDMO"
Most Viewed News
1
Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
2Samsung Electronics, target price of 200,000 won appears.. equivalent to 10 million won before stock split
3Samsung Electronics, 20 trillion operating profit in Q4..elevated expectations easily met
4KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year
5BTS 5th Album Release Announcement.."Filled with the Most BTS-like Music"
Pick for you
Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
Samsung Electronics, target price of 200,000 won appears.. equivalent to 10 million won before stock split
KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year
Stock Market Receives the Spirit of Jeoktomah.. First Day Breaks 4300 for the First Time
Samba Signs 1.1 Trillion Won Pharmaceutical Production Contract with European Pharmaceutical Company.. Acquisition of Local Production Plant in the US
Youngpoong·MBK Partners "Korea Zinc, Choi Yoon-bum Takes on High Risks to Secure Management Rights"
Photo·Video
Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
Samsung Electronics, target price of 200,000 won appears.. equivalent to 10 million won before stock split
Samsung Electronics, 20 trillion operating profit in Q4..elevated expectations easily met
KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year
powered by 